Pharmaceuticals
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
In this photo illustration, Eliquis is made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. Scott Olson | Getty Images Medicare is set to negotiate prices for 10 different drugs with manufacturers in a bid to make those costly treatments more affordable for older Americans – a […]
Read More
Opioid overdose antidote Narcan will be widely available over the counter next week
The opioid overdose antidote Narcan will be available over the counter in the coming days, a move that’s hoped to increase access to the lifesaving medication amid the country’s worsening opioid epidemic. Emergent BioSolutions, which makes the drug, said Wednesday that shipments were on their way to major retailers, including Walgreens, Walmart, Rite Aid and CVS. It […]
Read More
Here are the three most used drugs on the Medicare price negotiation list
Bottles of the drug Jardiance, made by Eli Lilly and Company, sit on a counter at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters Two blood thinners and a diabetes medication are the most widely used among a list of ten drugs that will be subject to price negotiations between manufacturers […]
Read More
Biden administration unveils first 10 drugs subject to Medicare price negotiations
Kubra Cavus | Istock | Getty Images The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans. President Joe Biden’s Inflation Reduction Act, which passed in a […]
Read More
The ADHD drug market is already stretched thin. Now it’s facing a back-to-school supply strain
Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc. Jb Reed | Bloomberg | Getty Images It’s been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — one of the most widely used medications for attention deficit hyperactivity disorder — and the supply strain could […]
Read More
Wegovy helps reduce heart failure symptoms in obese people, study says
A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, March 31, 2023. Jim Vondruska | Reuters Wegovy, the popular weight loss drug from Novo Nordisk, significantly reduced symptoms of a common type of heart failure in patients with obesity, according to a late-stage clinical […]
Read More
CDC expects new Covid vaccines from Pfizer, Moderna and Novavax to be available in mid-September
A sign advertises COVID-19 (coronavirus) vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, August 14, 2023. Brian Snyder | Reuters The Centers for Disease Control and Prevention expects updated Covid vaccines from Pfizer, Moderna and Novavax to be available to the public in mid-September, an agency official told reporters Thursday. That amounts to the […]
Read More
CVS pushes into making cheaper versions of complex drugs with new discount Humira
Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company’s new venture focused on securing, and in some cases co-producing, […]
Read More
Novavax says new Covid vaccine was effective against Eris variant in animal trials
A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. Dado Ruvic | Reuters Novavax’s new Covid vaccine generated a broad immune response against the now-dominant Eris variant and another fast-spreading strain of the virus […]
Read More
FDA approves Pfizer maternal RSV vaccine for infants
CFOTO | Future Publishing | Getty Images The Food and Drug Administration on Monday approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. Pfizer’s RSV shot is already approved and available in the U.S. for older adults. It’s now the second treatment […]
Read More